Wanjie Medical Device
Orthopedic, sports medicine, and tissue regeneration medical devices
About Wanjie Medical Device
Beijing Wanjie Medical Device Co., Ltd., also known as Wanjie Tianyuan, is a high-tech enterprise founded in 2006 that integrates R&D, production, sales, and foreign trade. The company specializes in minimally invasive orthopedics, particularly sports medicine and minimally invasive spine procedures, as well as tissue regeneration. Its product portfolio includes orthopedic consumables, sports medicine devices, spine products, and medical equipment such as 4K endoscopy systems and plasma surgery equipment.
Wanjie Tianyuan has developed over 20 implantable orthopedic repair products. Key innovative products that have received approval from China's National Medical Products Administration include an artificial ligament and a joint cartilage repair scaffold, which are expected to fill a gap in the domestic market. The company also manufactures disposable pulse lavage systems, anti-blocking pipes, and Ligament Augmentation and Reconstruction Systems (LARS). During the 2020 pandemic, the company developed and exported four types of epidemic prevention products to over ten countries.
Headquartered in Beijing's Daxing Biomedical Industry Base, Wanjie Tianyuan collaborates with research teams led by well-known experts. It has been recognized as a "Little Giant" enterprise in Beijing for its specialization and innovation and was ranked among China's top 20 medical device companies for R&D capability. The company serves both domestic and international markets, exporting its products globally.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 22.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- medical implants, Surgery, Orthopedic, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Feb 2025 | $14M | $55M | CAS Investment Management | ↗ |
| OtherOther financing | Apr 2021 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Wanjie Medical Device is 260 monthly website visits, up 766.7% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Wanjie Medical Device in the Dongcheng District ecosystem
The Wanjie Medical Device office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
CAS Investment Management
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Wanjie Medical Device on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Wanjie Medical Device’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









